{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_8973f20112565cc33d5cf65a0993a6a432e4f81497e2aad28915e868675e1976","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_8973f20112565cc33d5cf65a0993a6a432e4f81497e2aad28915e868675e1976","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"75ee256e96ffe162f7b43d2ee0156c31723e450aefa166c998201cbd957f0dff","published":"Wed, 27 May 2026 00:00:00 -0400","receipt_hash":"75ee256e96ffe162f7b43d2ee0156c31723e450aefa166c998201cbd957f0dff","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"75ee256e96ffe162f7b43d2ee0156c31723e450aefa166c998201cbd957f0dff","observed_at":"2026-05-27T04:43:18.926230Z","parent_run_hash":"6f581915edab4326e2b95fed7c82c2ee149e978d6d7c2443439442a927c31dfa","published":"Wed, 27 May 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2605.22468v2 Announce Type: replace-cross \nAbstract: Cross-subject generalization in biomedical time-series refers to training on data from some subjects and testing on unseen subjects.The key challenge is to suppress subject specific variability in BTS representations.Most existing methods implicitly suppress the variability through model building or subject adversarial learning, but rarely model it explicitly.We introduce spectral drift as a new perspective to characterize subject specific variability.Specifically, BTS signals under the same label often share consistent oscillatory structure, yet exhibit subject-dependent magnitude or phase shifts in specific frequency components, which we interpret as subject-specific variability. Building on this insight, we propose BioFormer.At its core is a Frequency-Band Alignment Module(FBAM) that generates band-wise modulation factors from the spectral distribution and adaptively adjusts amplitude and phase to align spectral structure, t","title":"BioFormer: Rethinking Cross-Subject Generalization via Spectral Structural Alignment in Biomedical Time-Series","url":"https://arxiv.org/abs/2605.22468","vendor":"arxiv_cs_ai"},"summary":"arXiv:2605.22468v2 Announce Type: replace-cross \nAbstract: Cross-subject generalization in biomedical time-series refers to training on data from some subjects and testing on unseen subjects.The key challenge is to suppress subject specific variability in BTS representations.Most existing methods implicitly suppress the variability through model building or subject adversarial learning, but rarely model it explicitly.We introduce spectral drift as a new perspective to characterize subject specific variability.Specifically, BTS signals under the same label often share consistent oscillatory structure, yet exhibit subject-dependent magnitude or phase shifts in specific frequency components, which we interpret as subject-specific variability. Building on this insight, we propose BioFormer.At its core is a Frequency-Band Alignment Module(FBAM) that generates band-wise modulation factors from the spectral distribution and adaptively adjusts amplitude and phase to align spectral structure, t","title":"BioFormer: Rethinking Cross-Subject Generalization via Spectral Structural Alignment in Biomedical Time-Series","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-05-27T04:43:18Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2605.22468"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:8355b8585c7e7d6e22e544a4673016d43c5ac845f52017cc81cdf51ae67b6cb69f0828323ebce234caf3eb2c1e6b3c1680a4c1e785c7c8723d36a8e3756fe800","signer":"crovia.substrate","subject":{"observed_at":"2026-05-27T04:43:18Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2605.22468"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"706f65c6515e854bd9ce4a60056908f2a0c260bad8da6cd9aa928bbc9bdc7cee","leaf_index":154003,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"b03b5cef91057bfb0ad9e60d9c90904a137b3e187a49ae8f9699dd98e5c4cf49","side":"left"},{"sibling":"7159ff4e9b6924019f9e6e30bd194e3d32e17142cc14fcfed410b03f1f4d3987","side":"left"},{"sibling":"afb8f6e9d6295808776a187f1624e08f8dbb93ea2b4b14146fc2799897bce232","side":"right"},{"sibling":"48ad545c993e39bc007d9dbb5f9b92c4a7ddcd99da4f7d4174cf4af269174b1f","side":"right"},{"sibling":"bdab384782c8f46c42b2d20c722e44775a1dc82aa539824853fd1584b03c24dd","side":"left"},{"sibling":"3f8a4c1da74f8ace63125682e65daad3f027c83e12545bed4e5e502497a69769","side":"right"},{"sibling":"cc672c1300e7193c9ebe208defb6285b8c64e30c3301a5c7d7a31eb02ac23e5d","side":"right"},{"sibling":"78f1bf1ac0323860fbf9acf5cd7ad4ff9898b7360db2cfe79e3301d2eb634202","side":"left"},{"sibling":"c14a4eb4b07d22a6a83f548cf6c304559dc63f0e53071e550ecc566dbba50b14","side":"left"},{"sibling":"3165125427a29042fc9d02858a59a68858dbdcb2e19d1afa5f6dd6a95cfbce6a","side":"right"},{"sibling":"04b9a68b8ec6fa37251564383c685c23ce69e5e031df4eae69f79a3a334b68bf","side":"right"},{"sibling":"816f233274bb10f5a122aac086a0c8c697b78fec67a4af55190bb596b7506fab","side":"left"},{"sibling":"d415e6939aee710631f5062799379b547d2c3e3d9a68f263bbb5a693285ab2ca","side":"left"},{"sibling":"374c02d15fb12bd356c179c94766043a982052c6132af8bfc15361b431ffa9f7","side":"right"},{"sibling":"35ca36cee447f0ef7064a25d55f59357c66901e31427729c4c1d8b14aa8adb6c","side":"left"},{"sibling":"990705096edf483cc877217308f731dc42d6f6d99f82880167bbdbbfef32560a","side":"right"},{"sibling":"dd265753d95fa2e2fb4f5768e37fab6f691ccff09ad60d0910ff7dc23bac9226","side":"right"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":154065,"merkle_root":"4993cfdc172e7880b60667f16789dc2e831ff000f81bb1ecba248e73f1510eca","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260527T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-05-27T05:37:36Z","sig_algorithm":"ed25519","signature":"76ecf118011540405e96506e6219752df04a2850632f2903dc6f10e08b98bc5a42c8d9e1cb5b7c5bf714479806a403df5f34399afa40c23fbb71493a1f77bd0c","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_8973f20112565cc33d5cf65a0993a6a432e4f81497e2aad28915e868675e1976"}}